(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with sr 144528 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deligia, F; Fernández-Ruiz, J; García-Arencibia, M; Gómez-Cañas, M; Goya, P; Hurst, DP; Jagerovic, N; Morales, P; Murineddu, G; Pazos, R; Pinna, GA; Ragusa, G; Reggio, PH | 1 |
Cooper, AG; Glass, M; Hook, S; MacDonald, C; Tyndall, JDA; Vernall, AJ | 1 |
2 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and sr 144528
Article | Year |
---|---|
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonists.
Topics: Camphanes; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2015 |
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.
Topics: Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Indoles; Ligands; Models, Molecular; Molecular Structure; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2018 |